Filed: 11/14/2022ACC: 0001104659-22-117428
📋 What this filing means
NORTHPOND VENTURES, LLC filed this quarterly 13F‑HR report disclosing 5 equity positions with a total reported market value of $142.7K. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
5
Positions
$142.7K
Total AUM (reported)
28.10M
Total Shares
Allocation by class
COM$142.7K100.0%
Portfolio Concentration
Top 3$121.5K85.1%
4–10$21.2K14.9%
Top 3 weight
85.1%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 28.10M
Sole
Full voting authority
28.10M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole5
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings5
Rows:
DICE THERAPEUTICS INC
SOLEShares3.29M
TypeSH
Market value$66.8K
46.80%
Sole
3.29M
Shared
0.00
None
0.00
VIGIL NEUROSCIENCE INC
SOLEShares4.21M
TypeSH
Market value$38.4K
26.88%
Sole
4.21M
Shared
0.00
None
0.00
CODEX DNA INC
SOLEShares9.84M
TypeSH
Market value$16.3K
11.45%
Sole
9.84M
Shared
0.00
None
0.00
ISOPLEXIS CORP
SOLEShares8.81M
TypeSH
Market value$15.2K
10.62%
Sole
8.81M
Shared
0.00
None
0.00
CANDEL THERAPEUTICS INC
SOLEShares1.94M
TypeSH
Market value$6.1K
4.26%
Sole
1.94M
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
DICE THERAPEUTICS INCSOLE | COM | 3.29M | SH | $66.8K 46.80% | 3.29M | 0.00 | 0.00 |
VIGIL NEUROSCIENCE INCSOLE | COM | 4.21M | SH | $38.4K 26.88% | 4.21M | 0.00 | 0.00 |
CODEX DNA INCSOLE | COM | 9.84M | SH | $16.3K 11.45% | 9.84M | 0.00 | 0.00 |
ISOPLEXIS CORPSOLE | COM | 8.81M | SH | $15.2K 10.62% | 8.81M | 0.00 | 0.00 |
CANDEL THERAPEUTICS INCSOLE | COM | 1.94M | SH | $6.1K 4.26% | 1.94M | 0.00 | 0.00 |